jan 1, 2015 - (Varma et al., 2015)
Description:
The introduction of intravitreal vascular endothelial growth factor (VEGF) inhibition in 2006 hugely reduced legal blindness rates and achieved considerable improvements in vision in neovascular AMD and diabetic macular edema (DME)Added to timeline:
Date:
jan 1, 2015
Now
~ 9 years and 5 months ago
